PREVICOX Launches New Missing Dog Campaign

PREVICOX, the most COX-2 specific canine NSAID on the market, is launching a brand new campaign to raise awareness of the prevalence of canine osteoarthritis amongst dog owners in the UK. PREVICOX Product Manager Claire Edmunds explains: “We know that approximately 20% of adult dogs suffer from OA, but less than 25% of these dogs are treated with NSAIDs in the UK*. That’s one in five dogs that may be enduring the pain and discomfort of a condition that can be improved. Most owners will put their dog’s loss of mobility down to old age, however, our aim with this campaign is to raise awareness of this condition with pet owners to encourage them to seek help from their vet for their pets, and assist vets in promoting treatments for this condition.” Veterinary surgeries can take part in the campaign in five easy steps: Step one Ask clients to complete the symptom checklist on routine visits. Step two Review completed checklists with your clients and complete an OA check if needed. Step three If warranted, prescribe OA treatment and give owners a take-home pack to assess the efficacy of treatment. Step four Retain completed checklists for every OA check performed. Step five Use a chart in the waiting room to highlight the number of ‘missing dogs’ your practice has found. To support the ‘Missing dogs’ campaign, Merial has produced the following materials:

• Waiting room materials – to draw owners’ attention to the signs and symptoms of OA, as many will put their dog’s loss of mobility down to plain ‘old age’.
• Symptom checklist – a handy leaflet for owners to work through and help identify dogs at risk.
• Take-home pack – a leaflet detailing how canine osteoarthritis affects dogs’ lives and how treatment can help, as well as a handy progress chart to track dogs’ improvement, and a free gift.

To find out more about taking part in the PREVICOX Missing Dog Campaign contact your Merial Territory Manager on 0870 6000 123. For more information on PREVICOX visit www.previcoxfordogs.co.uk *GFK Market Data Aug 2010

More from

• Animus launches SkinBond Multi for enhanced wound care
• IVC Evidensia reports 82% cut in Farm antibiotic use and 20% carbon emissions reduction
• Vet professionals flock to sign up to transformative locum platform
• The ProSalus Foundation launches urgent appeal for UK vets to support Ukrainian colleagues
• Vetsure Named Business of the Year at 2025 SME National Business Awards